These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 21314983)

  • 1. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.
    Harris M; Wang XG; Jiang Z; Phaeton R; Koba W; Goldberg GL; Casadevall A; Dadachova E
    Br J Cancer; 2013 Mar; 108(4):859-65. PubMed ID: 23385729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6.
    Phaeton R; Harris M; Jiang Z; Wang XG; Einstein MH; Goldberg GL; Casadevall A; Dadachova E
    Cancer Biol Ther; 2010 Nov; 10(10):1041-7. PubMed ID: 20861673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice.
    Phaeton R; Wang XG; Einstein MH; Goldberg GL; Casadevall A; Dadachova E
    Cancer; 2010 Feb; 116(4 Suppl):1067-74. PubMed ID: 20127955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.
    Phaeton R; Jiang Z; Revskaya E; Fisher DR; Goldberg GL; Dadachova E
    Cancer Med; 2016 Jan; 5(1):9-16. PubMed ID: 26625938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
    Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
    Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
    Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
    Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
    Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
    Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice.
    Peng S; Xing D; Ferrall L; Tsai YC; Roden RBS; Hung CF; Wu TC
    mBio; 2022 Feb; 13(1):e0325221. PubMed ID: 35089069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
    Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
    Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
    Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
    Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.